An alleged Mounjaro marketing dispute is at the center of former Eli Lilly and Co. sales representative Jennifer Mansion's lawsuit, which accuses the company of retaliation after she objected.
Mansion's complaint dates the end of her employment to Nov. 9, 2023. It says she had objected to Lilly's alleged promotion of Mounjaro for weight loss.
The complaint describes weight loss as a use that had not been approved at the time. The retaliation charge remains Mansion's allegation and is not an established court finding.
